Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-038214

Chief Operating Officer sold 1,388 shares at an average $42.54 ($59,050)

  • Chief Operating Officer acquired 2,834 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bruno Julianne · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-10 Exercise or conversion : show line 1 in the form +2,399 9,461 D
2025-03-11 Sale : show line 2 in the form −1,198 $42.42 $50,819 8,263 D
2025-03-11 Exercise or conversion : show line 3 in the form +435 8,698 D
2025-03-12 Sale : show line 4 in the form −190 $43.32 $8,231 8,508 D
Open-market sales · 1,388 sh · avg $42.54 · $59,050

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-03-10 Exercise or conversion : show line 5 in the form Restricted Stock Units −2,399 4,796 D
2025-03-11 Exercise or conversion : show line 6 in the form Restricted Stock Units −435 0 D
Loading xslF345X05/ownership.xml…